Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
CC transcript
Quarterly results
Appointed director
|
|
Viracta Therapeutics, Inc. (VIRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/30/2020 |
8-K
| Appointed a new director|
Docs:
|
"Agreement and Plan of Merger and Reorganization, by and among Sunesis Pharmaceuticals, Inc., Sol Merger Sub, Inc. and Viracta Therapeutics, Inc",
"Amendment to Amended and Restated Bylaws of Sunesis Pharmaceuticals, Inc",
"Form of Sunesis Pharmaceuticals, Inc. Support Agreement",
"Form of Viracta Therapeutics, Inc. Support Agreement",
"Form of Lock-Up Agreement",
"Form of Retention Benefits Letter between Sunesis Pharmaceuticals, Inc. and certain officers",
"Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement",
"Investor Presentation",
"Conference Call Script" |
|
| 07/29/2009 |
8-K
| Form 8-K - Current report |
| 04/03/2009 |
8-K
| Form 8-K - Current report |
|
|